Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Toward achieving precision health.

Gambhir SS, Ge TJ, Vermesh O, Spitler R.

Sci Transl Med. 2018 Feb 28;10(430). pii: eaao3612. doi: 10.1126/scitranslmed.aao3612. Review.

2.

Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.

Zanganeh S, Spitler R, Hutter G, Ho JQ, Pauliah M, Mahmoudi M.

Immunotherapy. 2017 Sep;9(10):819-835. doi: 10.2217/imt-2017-0041. Review.

PMID:
28877626
3.

Cell Labeling with Magneto-Endosymbionts and the Dissection of the Subcellular Location, Fate, and Host Cell Interactions.

Lee KR, Wakeel A, Chakraborty P, Foote CS, Kajiura L, Barrozo JC, Chan AC, Bazarov AV, Spitler R, Kutny PM, Denegre JM, Taft RA, Seemann J, Rice BW, Contag CH, Rutt BK, Bell CB 3rd.

Mol Imaging Biol. 2018 Feb;20(1):55-64. doi: 10.1007/s11307-017-1094-6.

4.

Characterization of Magneto-Endosymbionts as MRI Cell Labeling and Tracking Agents.

Brewer KD, Spitler R, Lee KR, Chan AC, Barrozo JC, Wakeel A, Foote CS, Machtaler S, Rioux J, Willmann JK, Chakraborty P, Rice BW, Contag CH, Bell CB 3rd, Rutt BK.

Mol Imaging Biol. 2018 Feb;20(1):65-73. doi: 10.1007/s11307-017-1093-7.

5.

Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues.

Zanganeh S, Hutter G, Spitler R, Lenkov O, Mahmoudi M, Shaw A, Pajarinen JS, Nejadnik H, Goodman S, Moseley M, Coussens LM, Daldrup-Link HE.

Nat Nanotechnol. 2016 Nov;11(11):986-994. doi: 10.1038/nnano.2016.168. Epub 2016 Sep 26.

6.

Protein corona: Opportunities and challenges.

Zanganeh S, Spitler R, Erfanzadeh M, Alkilany AM, Mahmoudi M.

Int J Biochem Cell Biol. 2016 Jun;75:143-7. doi: 10.1016/j.biocel.2016.01.005. Epub 2016 Jan 16. Review.

7.

Combination of low level light therapy and nitrosyl-cobinamide accelerates wound healing.

Spitler R, Ho H, Norpetlian F, Kong X, Jiang J, Yokomori K, Andersen B, Boss GR, Berns MW.

J Biomed Opt. 2015 May;20(5):051022. doi: 10.1117/1.JBO.20.5.051022.

8.

Comparison of laser and diode sources for acceleration of in vitro wound healing by low-level light therapy.

Spitler R, Berns MW.

J Biomed Opt. 2014 Mar;19(3):38001. doi: 10.1117/1.JBO.19.3.038001.

9.

Minimal-length Synthetic shRNAs Formulated with Lipid Nanoparticles are Potent Inhibitors of Hepatitis C Virus IRES-linked Gene Expression in Mice.

Dallas A, Ilves H, Shorenstein J, Judge A, Spitler R, Contag C, Wong SP, Harbottle RP, Maclachlan I, Johnston BH.

Mol Ther Nucleic Acids. 2013 Sep 17;2:e123. doi: 10.1038/mtna.2013.50.

10.

Nitrosyl-cobinamide (NO-Cbi), a new nitric oxide donor, improves wound healing through cGMP/cGMP-dependent protein kinase.

Spitler R, Schwappacher R, Wu T, Kong X, Yokomori K, Pilz RB, Boss GR, Berns MW.

Cell Signal. 2013 Dec;25(12):2374-82. doi: 10.1016/j.cellsig.2013.07.029. Epub 2013 Aug 3.

11.

cGMP-dependent protein kinase Iβ regulates breast cancer cell migration and invasion via interaction with the actin/myosin-associated protein caldesmon.

Schwappacher R, Rangaswami H, Su-Yuo J, Hassad A, Spitler R, Casteel DE.

J Cell Sci. 2013 Apr 1;126(Pt 7):1626-36. doi: 10.1242/jcs.118190. Epub 2013 Feb 15.

12.

Visualization of plasmid delivery to keratinocytes in mouse and human epidermis.

González-González E, Kim YC, Speaker TJ, Hickerson RP, Spitler R, Birchall JC, Lara MF, Hu RH, Liang Y, Kirkiles-Smith N, Prausnitz MR, Milstone LM, Contag CH, Kaspar RL.

Sci Rep. 2011;1:158. doi: 10.1038/srep00158. Epub 2011 Nov 15.

13.

In vitro evolution of ligands to the membrane protein caveolin.

Majumdar S, Hajduczki A, Vithayathil R, Olsen TJ, Spitler RM, Mendez AS, Thompson TD, Weiss GA.

J Am Chem Soc. 2011 Jun 29;133(25):9855-62. doi: 10.1021/ja201792q. Epub 2011 Jun 7.

14.

Non-damaging retinal phototherapy: dynamic range of heat shock protein expression.

Sramek C, Mackanos M, Spitler R, Leung LS, Nomoto H, Contag CH, Palanker D.

Invest Ophthalmol Vis Sci. 2011 Mar 28;52(3):1780-7. doi: 10.1167/iovs.10-5917.

PMID:
21087969
15.

Biodegradable nanoparticles with sustained release of functional siRNA in skin.

Jacobson GB, Gonzalez-Gonzalez E, Spitler R, Shinde R, Leake D, Kaspar RL, Contag CH, Zare RN.

J Pharm Sci. 2010 Oct;99(10):4261-6. doi: 10.1002/jps.22147.

PMID:
20737633
16.

Silencing of reporter gene expression in skin using siRNAs and expression of plasmid DNA delivered by a soluble protrusion array device (PAD).

Gonzalez-Gonzalez E, Speaker TJ, Hickerson RP, Spitler R, Flores MA, Leake D, Contag CH, Kaspar RL.

Mol Ther. 2010 Sep;18(9):1667-74. doi: 10.1038/mt.2010.126. Epub 2010 Jun 22.

17.

Increased interstitial pressure improves nucleic acid delivery to skin enabling a comparative analysis of constitutive promoters.

González-González E, Ra H, Spitler R, Hickerson RP, Contag CH, Kaspar RL.

Gene Ther. 2010 Oct;17(10):1270-8. doi: 10.1038/gt.2010.74. Epub 2010 May 13.

PMID:
20463756
18.

Neuroleptic malignant syndrome.

Masters JC, Spitler R.

J Psychosoc Nurs Ment Health Serv. 1986 Sep;24(9):10-6. No abstract available.

PMID:
2876097

Supplemental Content

Loading ...
Support Center